Is an L3-4 midline epidural steroid injection (ESI) medically necessary for a 45-year-old female with lumbar spinal stenosis, chronic back pain exacerbated by standing, and a history of significant relief from prednisone, despite lack of documented radiculopathy or neurogenic claudication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommendation: DENY

This request for L3-4 midline epidural steroid injection should be DENIED because the patient does not meet the policy's medical necessity criteria for radiculopathy, and current high-quality guidelines recommend against epidural steroid injections for non-radicular axial low back pain. 1

Clinical Case Summary

This is a 45-year-old female with:

  • Imaging-confirmed lumbar spinal stenosis at L3-4 and L4-5 with multilevel degenerative disc disease and facet arthropathy [@case documentation]
  • Axial back pain that worsens with standing and improves with forward flexion ("shopping cart syndrome") [@case documentation]
  • No radicular symptoms documented - specifically, no pain radiating below the knee, no dermatomal sensory changes, no weakness, no reflex abnormalities, and no positive straight leg raise test [@case documentation]
  • Significant but temporary relief from oral prednisone [@case documentation]
  • Failed conservative management including NSAIDs, gabapentin, and acetaminophen [@case documentation]

Why This Request Does Not Meet Medical Necessity

Missing Required Documentation for Radiculopathy

The policy explicitly requires documentation of radiculopathy, defined as pain in a dermatomal distribution AND at least one of the following objective findings: [@policy]

  • Weakness in specific myotomes - Not documented [@case documentation]
  • Sensory changes (altered light touch, pinprick, temperature, paresthesia, or numbness in dermatomal distribution) - Not documented [@case documentation]
  • Diminished, absent, or asymmetric reflexes - Not documented [@case documentation]
  • Positive straight leg raise test - Not documented [@case documentation]

The examination notes only document "strength 5/5 in the BLE" and "nonantalgic gait," which explicitly rules out weakness but does not address the other required neurological findings. [@case documentation]

Patient Has Axial Pain, Not Radicular Pain

The patient's symptoms are consistent with neurogenic claudication from spinal stenosis, not radiculopathy. [@case documentation] The policy does allow ESI for neurogenic claudication, but the documentation states "no radicular symptoms reported," which contradicts the assessment that lists "lumbar spinal stenosis with radiculopathy." [@case documentation]

True radiculopathy requires pain radiating below the knee in a specific dermatomal distribution (L3, L4, L5, or S1). [@11@] This patient has back pain that worsens with standing - classic neurogenic claudication - but no documented leg pain below the knee. [@case documentation]

Evidence-Based Guidelines Recommend Against ESI for This Indication

High-Quality Guidelines Are Strongly Against ESI for Non-Radicular Pain

The most recent high-quality guidelines (2023) provide strong recommendations against epidural steroid injections for axial low back pain without radiculopathy. 2 Specifically:

  • One high-quality guideline was strongly against ESI for chronic low back pain 2
  • One moderate-quality guideline stated "there is no evidence for the effectiveness of epidural corticosteroids in patients with non-radicular, nonspecific low back pain" 2
  • Another moderate-quality guideline recommended against offering spinal epidural steroid injections for non-radicular low back pain 2

Neurosurgery Guidelines Provide Only Weak Support

The Journal of Neurosurgery guidelines (2014 update) found only weak evidence that ESIs provide short-term relief of pain in patients with chronic low-back pain from degenerative lumbar disease. 2 The original 2005 guidelines stated that "the use of lumbar epidural injections is not recommended as a treatment option for long-term relief of chronic low-back pain." 2

Contradictory Evidence Exists But Quality Matters

While some lower-quality guidelines weakly support ESI for axial pain 2, the highest quality and most recent evidence (2023) is against this practice. 2 The American Academy of Neurology explicitly recommends against epidural steroid injections for non-radicular low back pain. 1

Risk-Benefit Analysis Does Not Favor Approval

Epidural steroid injections carry significant risks including: 2, 1

  • Dural puncture
  • Insertion-site infections
  • Cauda equina syndrome
  • Sensorimotor deficits
  • Discitis
  • Epidural granuloma
  • Retinal complications
  • Rare catastrophic complications including paralysis and death

Exposing this patient to these risks without meeting evidence-based indications for radiculopathy is not justified. 1

What Would Be Required for Approval

To meet medical necessity criteria, the documentation must include: [@policy, @11@]

  1. Repeat neurological examination documenting at least one of:

    • Specific muscle weakness in myotomal distribution
    • Dermatomal sensory loss (altered light touch, pinprick, temperature, or numbness)
    • Asymmetric, diminished, or absent reflexes
    • Positive straight leg raise test
  2. Clear documentation of radicular pain pattern - pain radiating below the knee in a specific dermatomal distribution (L3, L4, L5, or S1) [@11@]

  3. Correlation with imaging - the MRI findings must correspond to the specific nerve root causing the radicular symptoms [@policy]

Alternative Management Recommendations

For this patient with axial pain and neurogenic claudication without radiculopathy:

  • Consider facet-mediated pain evaluation - The patient has significant facet arthropathy at L3-4 and L4-5, and responded well to systemic steroids. Diagnostic facet blocks with the double-injection technique may be appropriate. 2

  • Physical therapy specifically for spinal stenosis - Conservative management should continue [@policy]

  • Gabapentin optimization - The patient is on gabapentin but dosing and efficacy are not documented [@case documentation]

  • Surgical evaluation - Given MRI-confirmed moderate stenosis and failed conservative management, surgical consultation may be more appropriate than ESI for axial pain [@case documentation]

Common Pitfalls in This Case

Do not confuse neurogenic claudication with radiculopathy. [1, @14@] While both can occur with spinal stenosis, they are distinct clinical entities with different treatment algorithms. ESI may be indicated for radiculopathy but not for isolated axial pain from stenosis. [@2@, 1]

Do not rely on the provider's assessment alone. [@policy] The assessment states "lumbar spinal stenosis with radiculopathy" but the history explicitly states "no radicular symptoms reported." The objective examination findings must support the diagnosis. [@case documentation]

Do not approve based on MRI findings alone. [@policy] The policy requires both imaging evidence AND clinical examination findings of nerve root compression. This patient has the imaging but lacks the clinical examination findings. [@policy, @case documentation]

References

Guideline

Denial of Epidural Steroid Injection for Lumbar Spinal Stenosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the initial medical treatment for patients with spinal canal stenosis experiencing muscle cramps around the spine?
What is the preferred diluent, Normal Saline Solution (NSS) or D5W (5% Dextrose in Water), for epidural steroid/facet block injections in patients with various medical histories, including allergies, kidney disease, diabetes, or glucose intolerance?
What is neurogenic claudication?
What is the management plan for a patient with dextroscoliosis in the thoracolumbar region and narrowing of the L1-L2, L2-L3, and L5-S1 intervertebral (Intervertebral Disc Spaces) spaces with potential severe radiculopathy?
What is the best course of treatment for a 71-year-old male with recurrent lower back pain due to severe multilevel degenerative disc disease, primarily at L5-S1, with significant spinal stenosis?
Is a lumbar epidural steroid injection (ESI) at L3-4 indicated for a 45-year-old female with a history of scoliosis, chronic back pain, and lumbar spinal stenosis, who has tried prednisone (corticosteroid), meloxicam (nonsteroidal anti-inflammatory drug), Tylenol (acetaminophen), ibuprofen (nonsteroidal anti-inflammatory drug), and gabapentin (anticonvulsant), with significant relief from prednisone, but no documented radiculopathy or neurogenic claudication?
Can hyperkalemia (high potassium levels) cause supraventricular tachycardia (SVT) in individuals with pre-existing heart conditions?
What is the best treatment for an elderly female patient with pyelonephritis (infection of the kidney) and potential impaired renal function?
Can supplements like L-glutamine that affect GABA (Gamma-Aminobutyric Acid) mask vitamin deficiencies in a patient with a history of Small Intestine Bacterial Overgrowth (SIBO) and malabsorption, who is taking Ativan (lorazepam) and has a potential vitamin E deficiency?
What is the next step for a 36-year-old female patient with persistently elevated Creatine Kinase (CK) MM levels, positive Antinuclear Antibody (ANA), and chronic muscle cramps, who is currently taking Seroquel (quetiapine) 250 mg and Abilify (aripiprazole) 15 mg, and has a history of elevated CK levels prior to starting a gym workout routine, with normal Glomerular Filtration Rate (GFR) and normal Liver Function Tests (LFTs), and is also taking Benztropine (benztropine) 0.5 mg twice daily?
What are the treatment options for a patient with Postural Orthostatic Tachycardia Syndrome (POTS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.